IL128670A - Method to obtain oestrogens from mares' urine - Google Patents
Method to obtain oestrogens from mares' urineInfo
- Publication number
- IL128670A IL128670A IL12867096A IL12867096A IL128670A IL 128670 A IL128670 A IL 128670A IL 12867096 A IL12867096 A IL 12867096A IL 12867096 A IL12867096 A IL 12867096A IL 128670 A IL128670 A IL 128670A
- Authority
- IL
- Israel
- Prior art keywords
- urine
- mixture
- water
- liquid
- adsorber resin
- Prior art date
Links
- 239000000262 estrogen Substances 0.000 title claims abstract description 74
- 210000002700 urine Anatomy 0.000 title claims abstract description 59
- 238000000034 method Methods 0.000 title claims abstract description 28
- 229920005989 resin Polymers 0.000 claims abstract description 64
- 239000011347 resin Substances 0.000 claims abstract description 64
- 239000000203 mixture Substances 0.000 claims abstract description 52
- 239000007788 liquid Substances 0.000 claims abstract description 43
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 32
- 238000010828 elution Methods 0.000 claims abstract description 21
- 239000000126 substance Substances 0.000 claims abstract description 21
- 239000007787 solid Substances 0.000 claims abstract description 16
- 238000005406 washing Methods 0.000 claims abstract description 16
- 239000003960 organic solvent Substances 0.000 claims abstract description 13
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims abstract description 11
- -1 aliphatic ketones Chemical class 0.000 claims abstract description 10
- 238000001179 sorption measurement Methods 0.000 claims abstract description 10
- 239000012465 retentate Substances 0.000 claims abstract description 9
- 239000012141 concentrate Substances 0.000 claims abstract description 7
- 238000005374 membrane filtration Methods 0.000 claims abstract description 6
- 150000002170 ethers Chemical class 0.000 claims abstract description 5
- 238000003795 desorption Methods 0.000 claims abstract description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 18
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 15
- 150000002148 esters Chemical class 0.000 claims description 11
- 239000002253 acid Substances 0.000 claims description 8
- 125000001931 aliphatic group Chemical group 0.000 claims description 4
- HVDGDHBAMCBBLR-UHFFFAOYSA-N enterolactone Chemical compound OC1=CC=CC(CC2C(C(=O)OC2)CC=2C=C(O)C=CC=2)=C1 HVDGDHBAMCBBLR-UHFFFAOYSA-N 0.000 description 7
- 238000004128 high performance liquid chromatography Methods 0.000 description 7
- 239000002904 solvent Substances 0.000 description 6
- 239000003814 drug Substances 0.000 description 5
- QTWJRLJHJPIABL-UHFFFAOYSA-N 2-methylphenol;3-methylphenol;4-methylphenol Chemical compound CC1=CC=C(O)C=C1.CC1=CC=CC(O)=C1.CC1=CC=CC=C1O QTWJRLJHJPIABL-UHFFFAOYSA-N 0.000 description 4
- 239000000470 constituent Substances 0.000 description 4
- 229930003836 cresol Natural products 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 229920001429 chelating resin Polymers 0.000 description 3
- 150000001896 cresols Chemical class 0.000 description 3
- 239000003480 eluent Substances 0.000 description 3
- JKKFKPJIXZFSSB-CBZIJGRNSA-M estrone 3-sulfate(1-) Chemical class [O-]S(=O)(=O)OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 JKKFKPJIXZFSSB-CBZIJGRNSA-M 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 230000008929 regeneration Effects 0.000 description 3
- 238000011069 regeneration method Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 150000003431 steroids Chemical class 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 239000008186 active pharmaceutical agent Substances 0.000 description 2
- 229910000272 alkali metal oxide Inorganic materials 0.000 description 2
- 150000001340 alkali metals Chemical class 0.000 description 2
- 229910001860 alkaline earth metal hydroxide Inorganic materials 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 150000007529 inorganic bases Chemical class 0.000 description 2
- 238000009434 installation Methods 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 238000001471 micro-filtration Methods 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000000638 solvent extraction Methods 0.000 description 2
- 238000001694 spray drying Methods 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 2
- 229910021653 sulphate ion Inorganic materials 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- BNHGVULTSGNVIX-UHFFFAOYSA-N 1-(2-ethoxyethoxy)ethanol Chemical compound CCOCCOC(C)O BNHGVULTSGNVIX-UHFFFAOYSA-N 0.000 description 1
- HUUTWYHKKBIOMQ-UHFFFAOYSA-N 3-[(3-hydroxyphenyl)methyl]-3h-furan-2-one Chemical compound OC1=CC=CC(CC2C(OC=C2)=O)=C1 HUUTWYHKKBIOMQ-UHFFFAOYSA-N 0.000 description 1
- 206010003439 Artificial menopause Diseases 0.000 description 1
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 125000005233 alkylalcohol group Chemical group 0.000 description 1
- 230000000507 anthelmentic effect Effects 0.000 description 1
- 229940124339 anthelmintic agent Drugs 0.000 description 1
- 239000000921 anthelmintic agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 150000004292 cyclic ethers Chemical class 0.000 description 1
- HPXRVTGHNJAIIH-UHFFFAOYSA-N cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 230000002070 germicidal effect Effects 0.000 description 1
- 238000002657 hormone replacement therapy Methods 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229920000831 ionic polymer Polymers 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 238000001728 nano-filtration Methods 0.000 description 1
- 238000002414 normal-phase solid-phase extraction Methods 0.000 description 1
- 238000011017 operating method Methods 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 239000003495 polar organic solvent Substances 0.000 description 1
- 229920005990 polystyrene resin Polymers 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 239000002594 sorbent Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Developmental Biology & Embryology (AREA)
- Steroid Compounds (AREA)
- Compounds Of Unknown Constitution (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Lubrication Of Internal Combustion Engines (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP1996/003820 WO1998008526A1 (de) | 1996-08-30 | 1996-08-30 | Verfahren zur gewinnung von oestrogenen aus stutenharn |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL128670A0 IL128670A0 (en) | 2000-01-31 |
| IL128670A true IL128670A (en) | 2001-05-20 |
Family
ID=8166300
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL12867096A IL128670A (en) | 1996-08-30 | 1996-08-30 | Method to obtain oestrogens from mares' urine |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0923381B1 (cs) |
| JP (1) | JP4285773B2 (cs) |
| AT (1) | ATE264109T1 (cs) |
| AU (1) | AU722739B2 (cs) |
| CA (1) | CA2263757C (cs) |
| CZ (1) | CZ298761B6 (cs) |
| DE (2) | DE19681621D2 (cs) |
| DK (1) | DK0923381T3 (cs) |
| ES (1) | ES2219694T3 (cs) |
| HK (1) | HK1021884A1 (cs) |
| HU (1) | HU228763B1 (cs) |
| IL (1) | IL128670A (cs) |
| NO (1) | NO318390B1 (cs) |
| PL (1) | PL185919B1 (cs) |
| PT (1) | PT923381E (cs) |
| SK (1) | SK281368B6 (cs) |
| WO (1) | WO1998008526A1 (cs) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10037389A1 (de) | 2000-08-01 | 2002-02-14 | Solvay Pharm Gmbh | Verfahren und Vorrichtung zur Anreicherung und Stabilisierung von konjugierten Oestrogenen aus Stutenharn |
| DE10159161A1 (de) | 2001-12-01 | 2003-06-18 | Solvay Pharm Gmbh | Verfahren zur Gewinnung von Oestrogenen aus Stutenharn |
| TWI252111B (en) * | 2001-12-14 | 2006-04-01 | Solvay Pharm Gmbh | Matrix film tablet with controlled release of a natural mixture of conjugated estrogens |
| TWI332400B (en) * | 2001-12-14 | 2010-11-01 | Solvay Pharm Gmbh | Preformulation for the tableting of natural mixtures of conjugated estrogens |
| US20040072814A1 (en) | 2002-10-11 | 2004-04-15 | Solvay Pharmaceuticals Gmbh | Method for obtaining a natural mixture of conjugated equine estrogens depleted in non-conjugated lipophilic compounds |
| AR041121A1 (es) * | 2002-10-11 | 2005-05-04 | Solvay Pharm Gmbh | Procedimiento para la obtencion de una mezcla natural de estrogenos conjugados |
| CN1332973C (zh) * | 2003-03-06 | 2007-08-22 | 深圳市海达克实业有限公司 | 结合态雌性激素的提取方法 |
| MXPA06000645A (es) | 2003-07-17 | 2006-03-30 | Solvay Pharm Gmbh | Procedimiento para la obtencion de una mezcla natural de estrogeno equinos conjugados. |
| US20070161779A1 (en) * | 2003-10-24 | 2007-07-12 | Thorgard Pharmaceuticals (Aust) Pty Ltd | Estrogen Extraction From Pregnant Animal Urine |
| US20140371180A1 (en) | 2013-06-14 | 2014-12-18 | Dr. Reddy's Laboratories Ltd. | Process for purification and isolation of estrogens |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL7111863A (cs) * | 1970-10-13 | 1972-04-17 | ||
| CS224881B1 (cs) * | 1981-10-21 | 1984-01-16 | Jiri Semenka | Prostředek pro izolaci celkových 17-oxosteroiďú z biologického materiálu na bázi sorbentů |
-
1996
- 1996-08-30 CA CA002263757A patent/CA2263757C/en not_active Expired - Fee Related
- 1996-08-30 AT AT96930139T patent/ATE264109T1/de active
- 1996-08-30 ES ES96930139T patent/ES2219694T3/es not_active Expired - Lifetime
- 1996-08-30 DE DE19681621T patent/DE19681621D2/de not_active Expired - Fee Related
- 1996-08-30 JP JP51119598A patent/JP4285773B2/ja not_active Expired - Fee Related
- 1996-08-30 EP EP96930139A patent/EP0923381B1/de not_active Expired - Lifetime
- 1996-08-30 SK SK245-99A patent/SK281368B6/sk not_active IP Right Cessation
- 1996-08-30 PT PT96930139T patent/PT923381E/pt unknown
- 1996-08-30 DE DE59610985T patent/DE59610985D1/de not_active Expired - Lifetime
- 1996-08-30 AU AU69304/96A patent/AU722739B2/en not_active Ceased
- 1996-08-30 CZ CZ0059899A patent/CZ298761B6/cs not_active IP Right Cessation
- 1996-08-30 HU HU9903776A patent/HU228763B1/hu not_active IP Right Cessation
- 1996-08-30 WO PCT/EP1996/003820 patent/WO1998008526A1/de active IP Right Grant
- 1996-08-30 PL PL96331884A patent/PL185919B1/pl unknown
- 1996-08-30 IL IL12867096A patent/IL128670A/en not_active IP Right Cessation
- 1996-08-30 DK DK96930139T patent/DK0923381T3/da active
-
1999
- 1999-02-26 NO NO19990952A patent/NO318390B1/no not_active IP Right Cessation
-
2000
- 2000-02-09 HK HK00100736A patent/HK1021884A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CZ59899A3 (cs) | 1999-06-16 |
| PL185919B1 (pl) | 2003-08-29 |
| WO1998008526A1 (de) | 1998-03-05 |
| DK0923381T3 (da) | 2004-05-10 |
| HUP9903776A2 (hu) | 2000-03-28 |
| NO990952L (no) | 1999-02-26 |
| EP0923381B1 (de) | 2004-04-14 |
| SK24599A3 (en) | 1999-10-08 |
| DE19681621D2 (de) | 1999-09-30 |
| IL128670A0 (en) | 2000-01-31 |
| CZ298761B6 (cs) | 2008-01-23 |
| NO318390B1 (no) | 2005-03-14 |
| DE59610985D1 (de) | 2004-05-19 |
| AU722739B2 (en) | 2000-08-10 |
| PT923381E (pt) | 2004-09-30 |
| ES2219694T3 (es) | 2004-12-01 |
| CA2263757A1 (en) | 1998-03-05 |
| CA2263757C (en) | 2007-10-23 |
| AU6930496A (en) | 1998-03-19 |
| HU228763B1 (hu) | 2013-05-28 |
| HK1021884A1 (en) | 2000-07-14 |
| EP0923381A1 (de) | 1999-06-23 |
| JP2000516938A (ja) | 2000-12-19 |
| JP4285773B2 (ja) | 2009-06-24 |
| ATE264109T1 (de) | 2004-04-15 |
| PL331884A1 (en) | 1999-08-16 |
| SK281368B6 (sk) | 2001-02-12 |
| NO990952D0 (no) | 1999-02-26 |
| HUP9903776A3 (en) | 2000-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2263757C (en) | Method to obtain oestrogens from mare's urine | |
| US5723454A (en) | Method for obtaining estrogens from pregnant mare urine by solid phase extraction on a semi-polar adsorber resin | |
| CA2263904C (en) | Process to obtain oestrogens from mare's urine | |
| AU2002352161B2 (en) | Method for obtaining oestrogen from mare urine | |
| US5814624A (en) | Method for obtaining estrogens from pregnant mare urine by solid-phase extraction | |
| CA2529009C (en) | Method for obtaining a natural mixture of conjugated equine estrogens | |
| RU2179028C2 (ru) | Способ извлечения эстрогенов из мочи кобылы | |
| RU2179029C2 (ru) | Способ получения эстрогенов из кобыльей мочи | |
| MXPA99001923A (es) | Procedimiento para la obtencion de estrogenos a partir de orina de yeguas | |
| MXPA99001851A (en) | Process to obtain oestrogens from mare's urine | |
| US20040072814A1 (en) | Method for obtaining a natural mixture of conjugated equine estrogens depleted in non-conjugated lipophilic compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| EXP | Patent expired |